Announce Date | 05/06/2025 |
EPS Normalized Actual | $0.17 (Beat by $0.0454) |
EPS GAAP Actual | $0.17 (Beat by $0.0454) |
Revenue Actual | $163.151B |
Revenue Surprise | Beat by $163151M |
Announce Date | 09/30/2025 (Pre-Market) |
EPS Normalized Estimate | $400.48183 |
EPS GAAP Estimate | $400.48183 |
Revenue Estimate | $0.31071717B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 1754.4 | 0.01 | 1583.9897 | 2017.87441 | 1 |
Dec 2028 | 1047.17897 | 0.01 | 432.48375 | 2348.17189 | 0 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 920.05 | 700.80806 | 163.151B | 29.6% | 162899.76M |
FQ4 2024 (Dec 2024) | 192.26 | 282.52439 | 174.173B | -124.16% | -23457.69M |
FQ3 2024 (Sep 2024) | 179.35 | 177.80859 | 180.686B | 58.94% | 66136.25M |
FQ2 2024 (Jun 2024) | 409.62 | 408.27741 | 219.572B | 76.81% | 117750M |
FQ1 2024 (Mar 2024) | 434.92 | 433.34355 | 114.851B | 100% | 25756.75M |
FQ3 2012 (Sep 2012) | 0.42 | 0.42 | 0.865484B | 100% | 865.48M |
FQ4 2012 (Dec 2012) | 0.82 | 0.82 | 0.92644B | 100% | 926.44M |
FQ1 2016 (Mar 2016) | 0.72 | 0.72 | 2.17159B | 100% | 2171.59M |
FQ4 Announce Date
09/30/2025 (Pre-Market)
Consensus EPS Estimates
400.48183
Consensus Revenue Estimates
0.31071717B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Dec 2026) | 609.85106 | -- | 609.85106 | 609.85106 | 0 |
FQ3 2026 (Sep 2026) | 488.42051 | -- | 488.42051 | 488.42051 | 0 |
FQ2 2026 (Jun 2026) | 318.25717 | -- | 318.25717 | 318.25717 | 0 |
FQ1 2026 (Mar 2026) | 489.70553 | -87.88 | 489.70553 | 489.70553 | 0 |
FQ4 2025 (Dec 2025) | 322.33792 | 40.35 | 322.33792 | 322.33792 | 0 |
FQ3 2025 (Sep 2025) | 400.48183 | 55.22 | 400.48183 | 400.48183 | 0 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Dec 2026) | 507.96B | -- | 507.96B | 507.96B | 0 |
FQ3 2026 (Sep 2026) | 437.1B | -- | 437.1B | 437.1B | 0 |
FQ2 2026 (Jun 2026) | 376.22B | -- | 376.22B | 376.22B | 0 |
FQ1 2026 (Mar 2026) | 403.68B | 59.58 | 403.68B | 403.68B | 0 |
FQ4 2025 (Dec 2025) | 310.49B | 43.9 | 310.49B | 310.49B | 0 |
FQ3 2025 (Sep 2025) | 0.31B | -58051.28 | 0.31B | 0.31B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 219.24194 | 920.05 | 700.80806 | 76.17% |
FQ4 2024 (Dec 2024) | -90.26439 | 192.26 | 282.52439 | 146.95% |
FQ3 2024 (Sep 2024) | 1.54141 | 179.35 | 177.80859 | 99.14% |
FQ2 2024 (Jun 2024) | 1.34259 | 409.62 | 408.27741 | 99.67% |
FQ1 2024 (Mar 2024) | 1.57645 | 434.92 | 433.34355 | 99.64% |
FQ3 2012 (Sep 2012) | 0.42 | 0.42 | 100% | |
FQ4 2012 (Dec 2012) | 0.82 | 0.82 | 100% | |
FQ1 2016 (Mar 2016) | 0.72 | 0.72 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0.25B | $163.15B | $162899.76M | 99.85% |
FQ4 2024 (Dec 2024) | $197.63B | $174.17B | $-23457.69M | -13.47% |
FQ3 2024 (Sep 2024) | $114.55B | $180.69B | $66136.25M | 36.6% |
FQ2 2024 (Jun 2024) | $101.82B | $219.57B | $117750M | 53.63% |
FQ1 2024 (Mar 2024) | $89.09B | $114.85B | $25756.75M | 22.43% |
FQ3 2012 (Sep 2012) | $0B | $0.87B | $865.48M | 100% |
FQ4 2012 (Dec 2012) | $0B | $0.93B | $926.44M | 100% |
FQ1 2016 (Mar 2016) | $0B | $2.17B | $2171.59M | 100% |